Menu

CytomX Therapeutics, Inc. CTMX

Full chart Compare
Set alert

Price alert · CTMX

All alert types
2.19 USD +0.05 (+2.34%)

At closeNov 6, 2026, 4:20 PM EST

2.19 0.00 0.00%

After hours · Nov 6, 4:20 PM ET

2.12 Day range 2.27
2.14 52-week range 6.75
YTD
-48.59%
1 year
-47.73%

Revenue & Expenses

Other Income → Expenses: $5.23MExpenses → Selling, General & Admin: $29.84MExpenses → Research & Development: $68.73MExpenses → Income Tax: $238.00KGross Profit → Expenses: $76.20MRevenue → Gross Profit: $76.20MNet Loss → Expenses: $17.37MOther Income$5.23MGross Profit$76.20MNet Loss$17.37MExpenses$98.80MSelling, General & Admin$29.84MResearch & Development$68.73MIncome Tax$238.00KRevenue$76.20M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

CTMX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
76.20M138.10M101.21M53.16M37.31M
76.20M138.10M101.21M53.16M37.31M
76.20M138.10M101.21M53.16M37.31M
98.56M113.11M107.70M154.50M153.35M
68.73M83.38M77.68M111.65M114.19M
29.84M29.73M30.02M42.85M39.16M
-22.36M25.00M-6.48M-101.33M-116.04M
238.00K224.00K3.89M00
-17.37M31.87M-569.00K-99.32M-115.87M
-20.37M31.87M-569.00K-99.32M-115.87M
-20.37M31.87M-569.00K-99.32M-115.87M
-17.37M31.87M-569.00K-99.32M-115.87M
-0.150.38-0.01-1.51-1.81
-0.150.38-0.01-1.51-1.81
-0.150.38-0.01-1.51-1.81
-17.13M32.09M3.32M-99.32M-115.87M
-17.13M32.09M3.32M-99.32M-115.87M
3.00M0000
137.94M84.44M73.81M65.74M64.15M
137.94M84.75M73.81M65.74M64.15M